Parallel Advisors’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.08K | Buy |
1,320
+489
| +59% | +$1.51K | ﹤0.01% | 2782 |
|
|
2025
Q1 | $2.9K | Hold |
831
| – | – | ﹤0.01% | 2852 |
|
|
2024
Q4 | $2.72K | Hold |
831
| – | – | ﹤0.01% | 2839 |
|
|
2024
Q3 | $3.2K | Hold |
831
| – | – | ﹤0.01% | 2745 |
|
|
2024
Q2 | $2.57K | Buy |
831
+281
| +51% | +$868 | ﹤0.01% | 2719 |
|
|
2024
Q1 | $1.42K | Hold |
550
| – | – | ﹤0.01% | 2873 |
|
|
2023
Q4 | $1.38K | Hold |
550
| – | – | ﹤0.01% | 2876 |
|
|
2023
Q3 | $1.12K | Hold |
550
| – | – | ﹤0.01% | 2957 |
|
|
2023
Q2 | $1.27K | Sell |
550
-122
| -18% | -$281 | ﹤0.01% | 2873 |
|
|
2023
Q1 | $2.04K | Buy |
672
+122
| +22% | +$370 | ﹤0.01% | 2770 |
|
|
2022
Q4 | $1.28K | Hold |
550
| – | – | ﹤0.01% | 2837 |
|
|
2022
Q3 | $1K | Sell |
550
-169
| -24% | -$307 | ﹤0.01% | 2803 |
|
|
2022
Q2 | $2K | Buy |
719
+169
| +31% | +$470 | ﹤0.01% | 2503 |
|
|
2022
Q1 | $2K | Hold |
550
| – | – | ﹤0.01% | 2522 |
|
|
2021
Q4 | $2K | Hold |
550
| – | – | ﹤0.01% | 2635 |
|
|
2021
Q3 | $2K | Hold |
550
| – | – | ﹤0.01% | 2609 |
|
|
2021
Q2 | $2K | Hold |
550
| – | – | ﹤0.01% | 2492 |
|
|
2021
Q1 | $2K | Hold |
550
| – | – | ﹤0.01% | 2414 |
|
|
2020
Q4 | $2K | Hold |
550
| – | – | ﹤0.01% | 2235 |
|
|
2020
Q3 | $2K | Buy |
+550
| New | +$2K | ﹤0.01% | 2232 |
|